Physician profile
Bryce D Brown
NPI 1205183035
$972.49
in general payments reported to CMS, 2019-2025
15 companies · $54.71 in 2025
The $54.71 reported for 2025 was less than what a typical Corneal and Contact Management provider received nationally (typical 2025 total: $227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $166 · 2020: $519 · 2021: $48.76 · 2022: $55.13 · 2023: $21.52 · 2024: $107 · 2025: $54.71.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $183.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $183.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $500.00 | 2020 | |
| Staar Surgical Company | $87.71 | 2019 | |
| Bausch & Lomb Americas INC. | $60.01 | 2024 | Alden Scleral Zenlens |
| Alcon Vision LLC | $57.83 | 2022-2024 | Dailies Total1 |
| Harrow Eye, LLC | $54.71 | 2025 | Vevye |
| Aerie Pharmaceuticals, INC. | $34.52 | 2019 | |
| Sun Pharmaceutical Industries INC. | $27.29 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $23.79 | 2024 | Xdemvy |
| Apellis Pharmaceuticals, INC. | $21.52 | 2023 | Syfovre |
| Biotissue Holdings INC. | $20.43 | 2022 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Novartis Pharmaceuticals Corporation | $19.11 | 2021 | |
| Allergan, INC. | $18.14 | 2021 | |
| Optovue, INC. | $16.52 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $11.51 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryce Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.